SEEK, a UK privately-owned drug-discovery group, reports preliminary successful trials of a new vaccine that provides lifetime protection against all influenza strains after single vaccination. The Seek’s press release says that the Universal Flu vaccine could be available for use in the next 3-5 years.
If you would like to make a comment, please fill out the form below.
Featured Reports
